Agrawal, P., Nikhade, P., Patel, A., Mankar, N., & Sedani, S. (2022). Bromelain: A Potent Phytomedicine. Cureus. 2022 Aug 11;14(8):e27876. doi: 10.7759/cureus.27876.
Amini, A., Ehteda, A., Moghaddam, S. M., Akhter, J., Pillai, K., & Morris, D. L. (2013). Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21). OncoTargets and therapy, 6, 403.
Báez, R., Lopes, M. T., Salas, C. E., & Hernández, M. (2007). In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain. Planta medica, 73(13), 1377-1383.
Bhatnagar, P., Pant, AB., Shukla, Y., Chaudhari, B., Kumar, P., & Gupta, KC. (2015) Bromelain nanoparticles protect against 7,12-dimethylbenz[a]anthracene induced skin carcinogenesis in mouse model. Eur J Pharm Biopharm. 2015 Apr;91:35-46. doi: 10.1016/j.ejpb.2015.01.015. Epub 2015 Jan 22. PMID: 25619920.
Bhatnagar, P., Pant, A. B., Shukla, Y., Panda, A., & Gupta, K. C. (2016). Hyaluronic Acid Grafted PLGA Copolymer Nanoparticles Enhance the Targeted Delivery of Bromelain in Ehrlich's Ascites Carcinoma. Eur. J. Pharm. Biopharm. 105, 176-192. 10.1016/j.ejpb.2016.06.002
Bhui, K., Prasad, S., George, J., & Shukla, Y. (2009). Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway. Cancer Lett. 2009 Sep 18; 282(2), 167-76. doi: 10.1016/j.canlet.2009.03.003.
Bhui, K., Tyagi, S., Srivastava, AK., Singh, M., Roy, P., Singh, R., & Shukla, Y. (2012). Bromelain inhibits nuclear factor kappa-B translocation, driving human epidermoid carcinoma A431 and melanoma A375 cells through G(2)/M arrest to apoptosis. Mol Carcinog. 2012 Mar; 51(3), 231-43. doi: 10.1002/mc.20769.
Castell, J. V., Friedrich, G. E. R. H. A. R. D., Kuhn, C. S., & Poppe, G. E. (1997). Intestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intake. American Journal of Physiology-Gastrointestinal and Liver Physiology, 273(1), G139-G146.
Chen, D., Love, KT., Chen, Y., Eltoukhy, AA., Kastrup, C., Sahay, G., Jeon, A., Dong, Y., & Whitehead, KA. (2012). Anderson, DG. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J Am Chem Soc. 2012 Apr 25;134(16):6948-51. doi: 10.1021/ja301621z.
Chobotova, K., Vernallis, AB., & Majid, FA. (2010). Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett. 2010 Apr 28; 290(2), 148-56. doi: 10.1016/j.canlet.2009.08.001.
Dave, S., Kaur, NJ., Nanduri, R., Dkhar, HK., Kumar, A., & Gupta, P. (2012). Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes. PLoS One. 2012; 7(1), e30831. doi: 10.1371/journal.pone.0030831.
Dhandayuthapani, B., Varghese, SH., Aswathy, RG., Yoshida, Y., Maekawa, T., & Sakthikumar, D. (2012). Evaluation of antithrombogenicity and hydrophilicity on zein swcnt electrospun fibrous nanocomposite scaffolds. Int J Biomater 2012, 2012, 1-12.
Eckert, K., Grabowska, E., Stange, R. A. I. N. E. R., Schneider, U., Eschmann, K. L. A. U. S., & Maurer, H. R. (1999). Effects of oral bromelain administration on the impaired immunocytotoxicity of mononuclear cells from mammary tumor patients. Oncology reports, 6(6), 1191-1200.
Gerard G: Anti-cancer therapy with bromelain. Agress, 3(1972), 261-274
Hassan, H. A., Diebold, S. S., Smyth, L. A., Walters, A. A., Lombardi, G., & Al-Jamal, K. T. (2019). Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chances. Journal of controlled release, 297, 79-90.
He, H., Zhang, Y., Gao, C., & Wu, J. (2009). “Clicked” magnetic nanohybrids with a soft polymerinterlayer. Chem. Commun, 13, 1655-1657.
He, H., Wang, L., Qiao, Y., Zhou, Q., Li, H., Chen, S., Yin, D., Huang, Q., & He, M. (2020). Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway. Front Pharmacol. 2020 Jan 10;10:1531. doi: 10.3389/fphar.2019.01531.
Juhasz, B., Thirunavukkarasu, M., Pant, R., Zhan, L., Penumathsa, S. V., Secor Jr, E. R., ... & Maulik, N. (2008). Bromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardium. American journal of physiology-Heart and circulatory physiology, 294(3), H1365-H1370.
Maurer, H. R. (20010). Bromelain: biochemistry, pharmacology and medical use. Cellular and Molecular Life Sciences 58, 9, 1234-1245.
Nieper, HA. (1974). A program for the treatment of cancer. Krebs, 6, 124-127.
Paroulek, AF., Jaffe, M., & Rathinavelu, A. (2009). The effects of the herbal enzyme bromelain against breast cancer cell line GI101A. FASEB J., 23, LB18.
Pezzani, R., Jiménez-Garcia, M., Capó, X., Sönmez, GE., Sharopov, F., Rachel, T., Yamthe, L., Ntieche, W., David, RA., Peddio, S., Zucca, P., Tsouh, F., Patrick, V., Martorell, M., Gulsunoglu-Konuskan, Z., Ydyrys, A., Bekzat, T., Gulmira, T., Hano, C., Sharifi-Rad, J., Calina, D. (2023). Anticancer properties of bromelain: State-of-the-art and recent trends. Frontiers in Oncology, 12. 10.3389/fonc.2022.1068778.
Rathnavelu, V., Alitheen, NB., Sohila, S., Kanagesan, S., Ramesh, R. Potential role of bromelain in clinical and therapeutic applications. Biomed Rep. 2016 Sep;5(3):283-288. doi: 10.3892/br.2016.720.
Taussig, DC., Vargaftig, J., Miraki-Moud, F., Griessinger, E., Sharrock, K., Luke, T., Lillington, D., Oakervee, H., Cavenagh, J., & Agrawal, SG. (2010). Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood, 115, 1976-1984.
Tysnes, BB., Maurer, HR., Porwol, T., Probst, B., Bjerkvig, R., & Hoover, F. (2001). Bromelain reversibly inhibits invasive properties of glioma cells. Neoplasia, 3, 469-479.
Varilla, C., Marcone, M., Paiva, L., & Baptista, J. (2021). Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary. Foods. 2021 Sep 23; 10(10), 2249. doi: 10.3390/foods10102249.
Yiheng, H., Jie, X., Huan, L., Shoukun, H., Jianqing, J., & Jingping, R. (2020). Ethylene response factors regulate ethylene biosynthesis and cell wall modification in persimmon (Diospyros kaki L.) fruit during ripening, Postharvest Biology and Technology, Vol. 168, 111255, ISSN 0925-5214, https://doi.org/10.1016/j.postharvbio.2020.111255.
Zavadova, E., Desser, L., & Mohr, T. (1995). Stimulation of reactive oxygen species production and cytotoxicity in human neutrophils in vitro and after oral administration of a polyenzyme preparation. Cancer Biother, 109, 147-152.
)